Clinical outcome for a novel unidirectional porous tricalcium phosphate applied to bone defects after resection of bone tumor.

Clinical outcome for a novel unidirectional porous tricalcium phosphate applied to bone defects after resection of bone tumor. - Clinical outcome of a novel unidirectional porous tricalcium phosphate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022186

Enrollment

Registered

2016-06-06

Start date

2016-07-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign bone tumor or bone disease

Interventions

1.Application of this material to bone defect after bone resection. 2.CT 3 times, laboratory examination 3 times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who diagnosed as benign bone tumor 2.Patients who applied this material to bone defect after bone resection. 3.Patients who gave written informed consent

Exclusion criteria

Exclusion criteria: Patients who do not consent to this study.

Design outcomes

Primary

Measure	Time frame
Radiograhic evaluation at 4weeks, 8weeks, 3monts, 6months, 9months, 12months after surgery)	—

Countries

Japan

Contacts

Public ContactKunihiro Ikuta

Nagoya University Graduate School of Medicine Department of Orthopaedic Surgery

k-ikuta@med.nagoya-u.ac.jp052-744-1908

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026